Adjuvant Palbociclib in Elderly Patients With Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage II|Breast Cancer Stage III
Interventions: DRUG: Palbociclib|DRUG: Docetaxel / cyclophosphamide|DRUG: doxorubicin/cyclophosphamide|DRUG: epirubicin/cyclophosphamide|DRUG: paclitaxel
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Collaborators: Pfizer|Swedish Association of Breast Oncologists|ETOP IBCSG Partners Foundation|German Adjuvant Breast Cancer Group|SOLTI Breast Cancer Research Group|UNICANCER|Gruppo Oncologico Italiano di Ricerca Clinica|Breast International Group